Nektar Therapeutics Earnings Per Share (Basic)
Nektar Therapeutics (NKTR) reported Earnings Per Share (Basic) of -$1.23 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- Nektar Therapeutics earnings per share, basic for the quarter ending 2026-06-30 was -$1.23.
- Nektar Therapeutics earnings per share, basic for the quarter ending 2026-03-31 was -$1.82.
- Nektar Therapeutics earnings per share, basic for the quarter ending 2025-12-31 was -$1.77, a 442.86% decline year-over-year.
- Nektar Therapeutics earnings per share, basic for the quarter ending 2025-09-30 was -$1.87.
- Nektar Therapeutics earnings per share, basic for fiscal 2025 was -$9.73.
- Nektar Therapeutics earnings per share, basic for fiscal 2024 was -$8.68.
- Nektar Therapeutics earnings per share, basic for fiscal 2023 was -$1.45.
- Nektar Therapeutics earnings per share, basic for fiscal 2022 was -$1.97.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.23 10-Q · filed 2026-08-14 | -$2.96 10-Q · filed 2026-08-14 | -$4.67 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$6.47 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2026-03-31 | -$1.82 10-Q · filed 2026-05-08 | -$3.59 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$5.46 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$8.09 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-12-31 | -$1.77 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$3.64 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$6.36 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$9.73 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | -$1.87 10-Q · filed 2025-11-07 | -$4.67 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$8.14 10-Q · filed 2025-11-07 | -$7.91 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-06-30 | -$2.95 10-Q · filed 2026-08-14 | -$6.57 10-Q · filed 2026-08-14 | -$6.07 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$8.72 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-03-31 | -$3.62 10-Q · filed 2026-05-08 | -$0.24 10-Q · filed 2025-05-09 | -$3.11 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$5.77 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$9.52 derived: net income ÷ weighted average shares · filed 2026-05-08 | |||
| 2024-12-31 | $0.52 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$2.14 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$5.89 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$8.68 10-K · filed 2026-03-13 | -$0.58 10-K · filed 2025-03-14 | |||
| 2024-09-30 | -$2.66 10-Q · filed 2025-11-07 | -$0.18 10-Q · filed 2024-11-08 | -$6.42 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$9.27 10-Q · filed 2025-11-07 | -$0.62 10-Q · filed 2024-11-08 | -$1.63 derived: net income ÷ weighted average shares · filed 2026-04-24 | ||
| 2024-06-30 | -$3.76 10-Q · filed 2025-08-08 | -$0.25 10-Q · filed 2024-08-09 | -$6.63 10-Q · filed 2025-08-08 | -$0.44 10-Q · filed 2024-08-09 | -$0.98 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$1.20 derived: net income ÷ weighted average shares · filed 2026-04-24 | ||
| 2024-03-31 | -$0.19 10-Q · filed 2025-05-09 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$0.92 derived: net income ÷ weighted average shares · filed 2026-04-24 | ||||
| 2023-12-31 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$1.45 10-K · filed 2025-03-14 | ||||
| 2023-09-30 | -$0.24 10-Q · filed 2024-11-08 | -$0.51 derived: net income ÷ weighted average shares · filed 2024-11-08 | -$1.23 10-Q · filed 2024-11-08 | -$1.55 derived: net income ÷ weighted average shares · filed 2026-04-24 | ||||
| 2023-06-30 | -$0.27 10-Q · filed 2024-08-09 | -$0.99 10-Q · filed 2024-08-09 | -$1.31 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$1.63 derived: net income ÷ weighted average shares · filed 2026-04-24 | ||||
| 2023-03-31 | -$0.73 10-Q · filed 2024-05-10 | -$1.04 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$1.36 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$2.21 derived: net income ÷ weighted average shares · filed 2026-04-24 | ||||
| 2022-12-31 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$0.63 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$1.48 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$1.97 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | -$0.31 10-Q · filed 2023-11-08 | -$1.17 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$1.65 10-Q · filed 2023-11-08 | -$2.44 derived: net income ÷ weighted average shares · filed 2024-03-05 | ||||
| 2022-06-30 | -$0.85 10-Q · filed 2023-08-09 | -$1.34 10-Q · filed 2023-08-09 | -$2.13 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$2.83 derived: net income ÷ weighted average shares · filed 2024-03-05 | ||||
| 2022-03-31 | -$0.49 10-Q · filed 2023-05-10 | -$1.27 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$1.98 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$2.66 derived: net income ÷ weighted average shares · filed 2024-03-05 | ||||
| 2021-12-31 | -$790.00 10-K · filed 2022-03-01 | -$1.49 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$2.18 derived: net income ÷ weighted average shares · filed 2024-03-05 | -$2.86 10-K · filed 2024-03-05 | ||||
| 2021-09-30 | -$0.70 10-Q · filed 2022-11-04 | -$1.39 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$2.07 10-Q · filed 2022-11-04 | -$2.72 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||||
| 2021-06-30 | -$0.69 10-Q · filed 2022-08-05 | -$1.37 10-Q · filed 2022-08-05 | -$2.02 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$2.62 derived: net income ÷ weighted average shares · filed 2023-02-28 | ||||
| 2021-03-31 | -$0.68 10-Q · filed 2022-05-06 | -$680.00 10-K · filed 2022-03-01 | -$1.33 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.94 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$2.39 derived: net income ÷ weighted average shares · filed 2023-02-28 | |||
| 2020-12-31 | -$0.65 10-K · filed 2022-03-01 | -$1.26 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.71 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$2.49 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | -$0.61 10-K · filed 2022-03-01 | -$1.06 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$1.84 10-Q · filed 2021-11-05 | |||||
| 2020-06-30 | -$0.45 10-K · filed 2022-03-01 | -$1.23 10-Q · filed 2021-08-06 | ||||||
| 2020-03-31 | -$0.78 10-K · filed 2022-03-01 | |||||||
| 2019-12-31 | -$0.64 10-K · filed 2021-02-26 | -$1.20 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$1.83 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$2.52 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | -$0.56 10-K · filed 2021-02-26 | -$1.19 derived: net income ÷ weighted average shares · filed 2021-02-26 | -$1.87 10-Q · filed 2019-11-07 | |||||
| 2019-06-30 | -$0.63 10-K · filed 2021-02-26 | -$1.31 10-Q · filed 2019-08-09 | ||||||
| 2019-03-31 | -$0.69 10-K · filed 2021-02-26 | |||||||
| 2018-12-31 | -$0.57 10-K · filed 2020-02-28 | -$1.12 derived: net income ÷ weighted average shares · filed 2021-02-26 | $4.51 derived: net income ÷ weighted average shares · filed 2021-02-26 | $4.02 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | -$0.56 10-K · filed 2020-02-28 | $5.09 derived: net income ÷ weighted average shares · filed 2020-02-28 | $4.63 10-Q · filed 2019-11-07 | |||||
| 2018-06-30 | $5.67 10-K · filed 2020-02-28 | $5.27 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | -$0.60 10-K · filed 2020-02-28 | |||||||
| 2017-12-31 | -$0.21 10-K · filed 2019-03-01 | $0.17 derived: net income ÷ weighted average shares · filed 2020-02-28 | -$0.21 derived: net income ÷ weighted average shares · filed 2020-02-28 | -$0.62 10-K · filed 2020-02-28 | ||||
| 2017-09-30 | $0.39 10-K · filed 2019-03-01 | $0.01 derived: net income ÷ weighted average shares · filed 2019-03-01 | -$0.41 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | -$0.39 10-K · filed 2019-03-01 | -$0.80 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | -$0.42 10-K · filed 2019-03-01 | |||||||
| 2016-12-31 | -$0.28 10-K · filed 2018-03-01 | -$0.60 derived: net income ÷ weighted average shares · filed 2019-03-01 | -$1.10 10-K · filed 2019-03-01 | |||||
| 2016-09-30 | -$0.32 10-K · filed 2018-03-01 | -$0.82 10-Q · filed 2017-11-08 | ||||||
| 2016-06-30 | -$0.36 10-K · filed 2018-03-01 | |||||||
| 2016-03-31 | -$0.14 10-K · filed 2018-03-01 | |||||||
| 2015-12-31 | -$0.40 10-K · filed 2017-03-01 | |||||||
| 2015-09-30 | -$0.06 10-K · filed 2017-03-01 | -$0.21 10-Q · filed 2015-11-06 | ||||||
| 2015-06-30 | -$0.40 10-K · filed 2017-03-01 | |||||||
| 2015-03-31 | $0.26 10-K · filed 2017-03-01 | |||||||
| 2014-12-31 | -$0.35 10-K · filed 2016-02-29 | |||||||
| 2014-09-30 | $0.55 10-K · filed 2016-02-29 | -$0.07 10-Q · filed 2015-11-06 | ||||||
| 2014-06-30 | -$0.26 10-K · filed 2016-02-29 | |||||||
| 2014-03-31 | -$0.37 10-K · filed 2016-02-29 | |||||||
| 2013-12-31 | -$0.41 10-K · filed 2015-02-26 | |||||||
| 2013-09-30 | -$0.14 10-K · filed 2015-02-26 | -$0.99 10-Q · filed 2014-11-07 | ||||||
| 2013-06-30 | -$0.37 10-K · filed 2015-02-26 | |||||||
| 2013-03-31 | -$0.48 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |